{"id":236,"date":"2026-08-13T05:03:57","date_gmt":"2026-08-13T05:03:57","guid":{"rendered":"https:\/\/dentaltransitions.com\/articles\/pros-cons-dental-practice-dso\/"},"modified":"2026-08-13T05:03:57","modified_gmt":"2026-08-13T05:03:57","slug":"pros-cons-dental-practice-dso","status":"publish","type":"post","link":"https:\/\/dentaltransitions.com\/articles\/pros-cons-dental-practice-dso\/","title":{"rendered":"Pros and Cons of Selling Your Dental Practice to a DSO"},"content":{"rendered":"<h2>Key Takeaways for Dental Practice Owners<\/h2>\n<ul>\n<li>\n<p>Headline DSO prices rarely equal cash received, because earnouts, rollover equity, and taxes can materially reduce net proceeds.<\/p>\n<\/li>\n<li>\n<p>DSO sales usually require multi-year employment commitments and restrictive covenants that limit clinical autonomy compared with private-buyer exits.<\/p>\n<\/li>\n<li>\n<p>Buyer quality varies widely. Several DSOs restructured in 2026, so checking financial health and leadership can be essential before accepting equity.<\/p>\n<\/li>\n<li>\n<p>Long-term modeling often shows the highest headline offer is not the highest after-tax outcome across different time horizons.<\/p>\n<\/li>\n<li>\n<p>McLerran &amp; Associates runs a competitive, multi-buyer process that has delivered about 30% higher valuations. <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Schedule a confidential discovery call<\/a> to compare both paths before speaking with any buyer.<\/p>\n<\/li>\n<\/ul>\n<h2>How DSOs and Private Buyers Value Your Practice<\/h2>\n<p>DSO buyers typically value practices on a multiple of EBITDA, or earnings before interest, taxes, depreciation, and amortization. EBITDA is essentially the practice&#8217;s operating profit after removing personal and one-time expenses. Private buyers more often price on a percentage of annual collections or a multiple of seller&#8217;s discretionary earnings (SDE), which is the total economic benefit flowing to one owner-dentist.<\/p>\n<p>The main valuation advantages of a DSO offer include:<\/p>\n<ul>\n<li>\n<p>DSOs can pay a meaningful premium over private buyers, especially for practices above $1.5M in revenue.<\/p>\n<\/li>\n<li>\n<p>Rollover equity, which is the portion of proceeds reinvested as an ownership stake in the DSO, can create a second payout if the platform later recapitalizes or sells.<\/p>\n<\/li>\n<li>\n<p>Specialty practices and multi-location groups can attract higher multiples than a private buyer can usually finance.<\/p>\n<\/li>\n<\/ul>\n<p>The tradeoffs on valuation can be significant:<\/p>\n<ul>\n<li>\n<p>Only a portion of the headline price is usually paid as guaranteed cash at close, with the rest deferred through earnouts and equity.<\/p>\n<\/li>\n<li>\n<p>Rollover equity is illiquid for several years until the next liquidity event, and its value depends entirely on the DSO&#8217;s financial health.<\/p>\n<\/li>\n<li>\n<p>Purchase price allocation, which is how the sale price is divided among goodwill, equipment, and restrictive covenants, can shift the seller&#8217;s tax bill. Goodwill is often taxed at long-term capital gains rates, while other allocations may be taxed as ordinary income.<\/p>\n<\/li>\n<\/ul>\n<p>Deal structure mechanics can be some of the main factors that determine what you actually keep. A standard DSO deal often includes a majority of the value paid as cash at close, a portion as rollover equity into the DSO&#8217;s parent company, and an earnout tied to post-close EBITDA maintenance. It also commonly includes a working-capital adjustment and an indemnification escrow. An independent sell-side advisor can shape the narrative around EBITDA add-backs, which are the adjustments that convert reported profit into true operating profit, so the number that anchors the deal is defensible and less likely to be reduced in due diligence.<\/p>\n<h2>Post-Sale Work and Restrictions After a DSO Deal<\/h2>\n<p>A DSO sale rarely functions as a clean exit, because most owners keep working in the practice for several years. The main advantages of these post-close arrangements include:<\/p>\n<ul>\n<li>\n<p>Administrative work such as billing, HR, payroll, and compliance usually shifts to the DSO, so the dentist can focus more on clinical care.<\/p>\n<\/li>\n<li>\n<p>A guaranteed base salary plus a production bonus can provide income certainty during the employment period.<\/p>\n<\/li>\n<li>\n<p>Infrastructure support can reduce the operational burden that often pushes owners to consider selling.<\/p>\n<\/li>\n<\/ul>\n<p>The obligations can feel heavy if they are not negotiated carefully:<\/p>\n<ul>\n<li>\n<p>DSO acquisitions usually require a multi-year employment commitment, while private-buyer transitions often involve a shorter handoff period.<\/p>\n<\/li>\n<li>\n<p>Non-compete covenants in DSO deals can set a wide geographic scope and long duration, and buyer drafts often start broader than necessary and require negotiation.<\/p>\n<\/li>\n<li>\n<p>Production quotas, approved supplier lists, and treatment-plan oversight can limit clinical autonomy in ways that may not be obvious from the employment agreement alone.<\/p>\n<\/li>\n<\/ul>\n<p>Employment-contract details can strongly influence how the sale feels after closing. An advisor who negotiates these terms every week can push for non-punitive earnout provisions, a later earnout start date to account for integration disruption, and non-compete language that does not leave the owner stranded if the relationship deteriorates.<\/p>\n<h2>Evaluating DSO Buyer Quality and Cultural Fit<\/h2>\n<p>Not every DSO functions as a strong long-term partner for a dental practice. The broader DSO buyer pool does offer several potential advantages:<\/p>\n<ul>\n<li>\n<p>Well-capitalized DSOs bring infrastructure such as technology, group purchasing, and compliance systems that can improve the environment for staff and patients.<\/p>\n<\/li>\n<li>\n<p>A strong DSO partner can fund growth that an individual buyer might not be able to support.<\/p>\n<\/li>\n<li>\n<p>Staff usually keep their roles, and clinical team members are commonly retained to maintain patient experience.<\/p>\n<\/li>\n<\/ul>\n<p>The risks can be meaningful if buyer quality is weak:<\/p>\n<ul>\n<li>\n<p>Several large DSOs entered restructuring agreements in early 2026, which showed that rollover equity in an undercapitalized platform can lose significant value.<\/p>\n<\/li>\n<li>\n<p>Administrative changes after closing can trigger staff turnover that affects patient experience and earnout performance.<\/p>\n<\/li>\n<li>\n<p>Equity held at the holding-company level, which is the DSO&#8217;s parent entity, can offer more upside but no interim distributions and higher risk than equity held at the joint-venture level, which usually provides distributions but a lower ceiling.<\/p>\n<\/li>\n<\/ul>\n<p>Most owners feel underprepared when they try to vet buyer quality on their own. McLerran &amp; Associates blacklists DSOs known for poor post-close environments and helps owners review a buyer&#8217;s profitability, leadership, and financial backing before any offer is accepted.<\/p>\n<h2>Comparing Long-Term Economics Across Exit Paths<\/h2>\n<p>Long-term economics can be one of the main reasons owners choose or avoid a DSO sale. The potential advantages include:<\/p>\n<ul>\n<li>\n<p>A successful DSO recapitalization can multiply the value of rollover equity, which can create a second liquidity event that exceeds the original cash at close.<\/p>\n<\/li>\n<li>\n<p>Reduced operational responsibility during the employment period can improve quality of life while income continues.<\/p>\n<\/li>\n<\/ul>\n<p>The long-term tradeoffs can be substantial:<\/p>\n<ul>\n<li>\n<p>Owners who stay on as clinical associates after a DSO sale often see compensation fall to a lower percentage of collections compared with the effective rate they earned as practice owners after normalized distributions.<\/p>\n<\/li>\n<li>\n<p>Earnout realization is not guaranteed. Across documented DSO sales, mean realization has ranged from a portion of face value for well-structured earnouts, with some outcomes falling much lower.<\/p>\n<\/li>\n<li>\n<p>A multi-year cash-flow model that compares keeping the practice, selling to a private buyer, and each DSO deal structure often shows that the highest headline number does not always create the highest net outcome.<\/p>\n<\/li>\n<\/ul>\n<p>McLerran &amp; Associates produces multi-year, multi-structure financial forecasts for every engagement so owners can compare after-tax proceeds across time horizons instead of focusing only on headline numbers. These models often reveal how different combinations of cash, equity, and earnouts can affect what owners and their families actually keep over 5 to 10 years.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231605342-03c5ed4725a3.jpeg\" alt=\"At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>At McLerran &amp; Associates, every engagement is built on an ironclad, CPA-led EBITDA analysis and practice valuation.<\/em><\/figcaption><\/figure>\n<h2>Sample Net Outcomes for a $2M EBITDA Practice<\/h2>\n<p>The following illustration shows how a $2M EBITDA practice might net out under a DSO sale versus a private-buyer sale. It highlights why a higher DSO headline offer does not always translate into more money in the owner&#8217;s pocket once deferred proceeds and tax treatment are considered.<\/p>\n<p>The table below presents estimated net-proceed ranges for a practice generating $2M in adjusted EBITDA. Every figure is a range drawn from published deal-structure data. Individual outcomes can vary based on entity type, tax planning, buyer, and negotiation. Consult a qualified CPA and legal advisor before drawing conclusions from any illustration.<\/p>\n<table style=\"min-width: 75px;\">\n<colgroup>\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\">\n<col style=\"min-width: 25px;\"><\/colgroup>\n<tbody>\n<tr>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Dimension<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>DSO Sale (estimated range)<\/p>\n<\/th>\n<th colspan=\"1\" rowspan=\"1\">\n<p>Private Buyer Sale (estimated range)<\/p>\n<\/th>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Headline enterprise value<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>$14M\u2013$18M (7\u00d7\u20139\u00d7 EBITDA for multi-doctor group)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Lower; private buyers typically pay a percentage of annual collections or SDE-based multiples<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Cash at close (guaranteed)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>A majority of headline value<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Typically a high percentage of agreed price, all cash<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Deferred \/ at-risk proceeds<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>A portion in rollover equity (illiquid for several years) plus an earnout<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Minimal to none; brief transition only<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Estimated after-tax net (illustrative)<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Post-tax range typically a portion of headline, depending on allocation, entity type, and tax planning; equity and earnout proceeds realized over several years<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\n<p>Higher immediate after-tax certainty on a lower headline; no illiquid equity risk<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Common Pitfalls That Quietly Reduce Proceeds<\/h2>\n<p>Three recurring mistakes account for a large share of value lost in dental practice transitions.<\/p>\n<ul>\n<li>\n<p><strong>Accepting a single DSO offer.<\/strong> Sellers who run a multi-bid process across several DSO buyers can often achieve a higher final offer than single-bid starting points, because competing bids create pressure on each buyer to present strong terms. Without that competitive tension, a single offer leaves you with no benchmark and no way to know whether the market would pay 10% or 30% more.<\/p>\n<\/li>\n<li>\n<p><strong>Relying on a free valuation.<\/strong> A quick number set by the buyer can become the anchor for the entire negotiation. Quality-of-earnings reviews in 2026 DSO transactions have grown more confrontational than in prior years, and a weak valuation analysis can be reduced during due diligence.<\/p>\n<\/li>\n<li>\n<p><strong>Overlooking non-compete length and earnout conditions.<\/strong> Agreement terms beyond headline price, including restrictive covenants and purchase price allocation, can shift net proceeds. Earnout claw-backs tied to associate retention or production thresholds can eliminate deferred proceeds entirely.<\/p>\n<\/li>\n<\/ul>\n<h2>How an Independent Sell-Side Process Can Change Your Outcome<\/h2>\n<p>McLerran &amp; Associates has completed approximately 2,000 successful practice sales representing roughly $2 billion in closed transaction volume, with a transaction rate of about 85\u201390% compared with an industry norm closer to 35\u201340%. The firm&#8217;s structured, auction-style bid process typically generates around 10 offers within 45\u201360 days, and clients on average achieve approximately 30% higher valuations than owners who sell on their own.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231581955-2aa75d9d4697.jpeg\" alt=\"McLerran &amp; Associates team: McLerran is the nation's largest dental-specific sell-side M&amp;A advisory and brokerage firms\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>McLerran &amp; Associates team: McLerran is the nation&#8217;s largest dental-specific sell-side M&amp;A advisory and brokerage firms<\/em><\/figcaption><\/figure>\n<p>That valuation premium usually comes from three mechanics. A CPA-led EBITDA analysis is completed before the deal goes to market so the number holds under buyer scrutiny. A vetted buyer pool excludes poorly run DSOs that create post-close risk. Quality-of-earnings defense through due diligence helps prevent the agreed value from being reduced. Because McLerran works both the private-buyer and DSO paths in roughly equal measure, owners receive a genuine side-by-side comparison instead of a recommendation shaped by a single preferred path.<\/p>\n<p>Find out what your practice may be worth in both markets. <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Schedule a confidential discovery call with McLerran &amp; Associates<\/a> before committing to either path.<\/p>\n<h2>Summary and Practical Next Step<\/h2>\n<p>Four dimensions often determine what an owner actually keeps. Valuation and net proceeds cover the relationship between headline price and guaranteed cash after taxes and allocation. Post-close obligations include employment terms, non-competes, and production splits. Buyer quality and fit involve checking the DSO&#8217;s financial health and cultural alignment. Long-term economics rely on multi-year cash-flow modeling across deal structures. No single dimension tells the full story, and the right path can depend on practice size, profitability, and the owner&#8217;s personal goals.<\/p>\n<p>The largest financial decision of a dental career usually deserves diligence-grade analysis and a competitive process, not a single offer and a free valuation. McLerran &amp; Associates has guided owners through approximately 2,000 transitions and is one of the few firms that runs both paths at scale, with the buyer pool, underwriting, and advocacy to help change the outcome.<\/p>\n<p>Explore what a transition could look like for your practice. <a target=\"_blank\" rel=\"noopener noreferrer nofollow\" href=\"https:\/\/dentaltransitions.com\/contact-us\/\">Connect with McLerran &amp; Associates<\/a>, call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com\/contact-us.<\/p>\n<figure style=\"text-align: center;\"><img src=\"https:\/\/cdn.aigrowthmarketer.co\/1782231776232-426cf610db07.jpeg\" alt=\"A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.\" style=\"max-height: 500px;\" loading=\"lazy\" decoding=\"async\"><figcaption><em>A chat at McLerran &amp; Associates: the dental-specific sell-side advisor and advocate for practice owners guides on how, when, and to whom to sell your practice.<\/em><\/figcaption><\/figure>\n<h2>Frequently Asked Questions<\/h2>\n<h3>How do I know whether to sell to a DSO or a private buyer?<\/h3>\n<p>The right path can depend on practice size, profitability, and what the owner wants from the transition. Practices in the roughly $1\u20131.5M revenue range often fit a doctor-to-doctor sale well, while larger practices above $3M in revenue tend to attract stronger DSO interest. Owners in the $1.5\u20133M revenue range can often pursue either path, which is why a side-by-side valuation that shows the practice&#8217;s worth in both markets can be one of the most useful tools before making any decision. Because McLerran &amp; Associates works both paths in roughly equal measure, it can produce that comparison without a built-in bias toward either outcome.<\/p>\n<h3>What happens to my staff and patients after a DSO acquisition?<\/h3>\n<p>In many DSO acquisitions, clinical staff are retained as part of the deal because operational continuity is a core part of what the buyer is purchasing. Administrative roles can sometimes change as the DSO implements its own systems for HR, billing, and compliance. Patient attrition after an ownership change is one of the primary risks DSO buyers evaluate, and practices that rely on systems rather than only on the founding dentist&#8217;s relationships tend to retain patients at higher rates.<\/p>\n<p>A well-structured transition plan, including a letter from the founding dentist and a clear introduction to the new ownership, can materially reduce attrition. Choosing a buyer whose culture and support model align with the practice&#8217;s existing environment can be a meaningful part of protecting both staff and patients, and this review is a core part of what McLerran &amp; Associates evaluates in the buyer-vetting process.<\/p>\n<h3>Is the earnout in a DSO deal likely to be paid in full?<\/h3>\n<p>Earnout realization is not guaranteed, and outcomes across documented DSO transactions can vary widely. Earnouts are typically tied to production or EBITDA targets measured over 12\u201336 months after closing. Factors outside the seller&#8217;s control, such as associate turnover, integration disruption, or changes in the DSO&#8217;s operational priorities, can affect whether those targets are met.<\/p>\n<p>Well-structured earnouts often include pro-rata catch-up provisions so that a near-miss on a target still pays most of the earnout, along with a later start date to account for the integration period. Negotiating those protections before signing a letter of intent can be one of the most valuable contributions an experienced sell-side advisor makes for a selling dentist.<\/p>\n<h3>Why does it matter whether my rollover equity is held at the joint-venture level or the holding-company level?<\/h3>\n<p>The level at which equity is held can meaningfully affect both risk and potential return. Joint-venture equity, which is held at the individual practice or regional group level, usually provides interim distributions and a more direct connection to the practice&#8217;s own performance, creating a higher floor but a lower ceiling. Holding-company equity, which is held at the DSO&#8217;s parent entity, usually provides no interim distributions but can multiply several times over if the platform achieves a successful recapitalization or sale at a higher multiple.<\/p>\n<p>As much as 40% of a DSO deal can be structured as equity rather than cash. Understanding which level the equity sits at, and reviewing the DSO&#8217;s financial health and growth trajectory accordingly, can be as important as negotiating the headline price itself.<\/p>\n<h3>What does a competitive sell-side process actually look like, and how long does it take?<\/h3>\n<p>A structured sell-side process typically begins with a CPA-led EBITDA analysis and a comprehensive practice valuation, which are completed before the practice goes to market so the numbers are defensible when buyers review them. The advisor then builds a marketing deck and a virtual data room and solicits offers from a vetted pool of qualified buyers.<\/p>\n<p>McLerran &amp; Associates&#8217; DSO bid process typically runs 45\u201360 days and generates around 10 offers, which are then narrowed to in-person meetings with the top finalists. The advisor negotiates the letter of intent, manages due diligence, defends the EBITDA analysis against buyer pushback, and supports the transaction through closing. The entire process from engagement to close on a DSO deal commonly runs 3\u20136 months, compared with 60\u2013120 days for a private-buyer transaction.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Selling to a DSO? McLerran helps dental owners compare net proceeds, autonomy trade-offs, and buyer quality before signing. Get expert guidance today.<\/p>\n","protected":false},"author":1,"featured_media":235,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-236","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/comments?post=236"}],"version-history":[{"count":0,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/posts\/236\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media\/235"}],"wp:attachment":[{"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/media?parent=236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/categories?post=236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dentaltransitions.com\/articles\/wp-json\/wp\/v2\/tags?post=236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}